## Abstract The effect of cancerโassociated galactosyltransferase acceptor (CAGA) on incorporation of a variety of macromolecular precursors has been studied in transformed and nontransformed cells. Incorporation of [^3^H]โmannose, [^3^H]โgalactose, and [^3^H]โglucosamine into acid precipitable mat
Cancer-associated galactosyltransferase acceptor. Inhibition of transformed cell and tumor growth
โ Scribed by Daniel K. Podolsky; Kurt J. Isselbacher
- Publisher
- John Wiley and Sons
- Year
- 1980
- Tongue
- English
- Weight
- 579 KB
- Volume
- 45
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## Abstract UDPgalactose inhibits the growth of mouse leukemic L1210 cells. In calf serum supplemented Dulbecco's medium (CSโDMEM), 1.2 mM UDPgalactose (UDPgal) inhibited cell growth by 50% (IC~50~), and 5 mM UDPgalactose inhibited cell growth by 92%. Other nucleotide sugars as well as galactose, g
## Abstract Colorectal cancer is the third most common form of malignancy, behind prostate and lung cancers. Despite recent advances in medicine, mortality from colorectal cancer remains high, highlighting the need for improved therapies. Numerous studies have demonstrated increased activation of E
Infection of freshly established malignant human tumor cells with the adeno-associated viruses AAV-2 or AAV-5 inhibits cell proliferation. Normal human fibroblasts are also affected, but appear to partially escape the inhibition. In cell cultures of permanent lines of human and rodent origin, cell n
## Abstract Rat embryo fibroblasts (REF) morphologically transformed by herpes simplex virus type 2 (HSVโ2) and tumorโderived cells were tested for ability to grow in the presence of 9โ(2โhydroxyethoxymethyl) guanine (acyclovir). Results indicated that the effective dose of acyclovir (ACV) required
Fifty-one patients with confirmed bladder cancer have enrolled in a prospective evaluation of BCG immunotherapy. Following resection of existing tumors, patients were stratified according to tumor grade and number of previous recurrences and randomly assigned to control or BCG treatment groups. Immu